Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Nov 10;10(1):321.
doi: 10.1186/s13256-016-1113-2.

Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report

Affiliations
Case Reports

Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report

Hiroki Kobayashi et al. J Med Case Rep. .

Abstract

Background: Extraskeletal myxoid chondrosarcoma is a rare soft tissue sarcoma that has unusual ultrastructural and molecular features. However, unlike other soft tissue sarcomas, it does not have specific clinical symptoms or radiological features, which can make its diagnosis difficult. Nevertheless, extraskeletal myxoid chondrosarcoma has a rare gene fusion (EWSR1-NR4A3) that is useful for making a differential diagnosis.

Case presentation: A 43-year-old Japanese man presented with a soft tissue mass in his right thigh. A physical examination and radiography revealed a large soft tissue mass. During magnetic resonance imaging, the mass exhibited isointensity on T1-weighted images and high intensity on T2-weighted images, as well as gadolinium enhancement at the side edge of the partition structure. Thus, we considered a possible diagnosis of a malignant myxoid soft tissue tumor, such as myxoid liposarcoma, myxofibrosarcoma, or metastatic carcinomas, including myoepithelial tumor and neuroendocrine tumor, and performed an incisional biopsy to make a definitive diagnosis. The pathological findings revealed a lobulated tumor with a myxoid structure and atypical spindle-shaped cells that created eosinophilic cord-like forms. Immunohistochemistry revealed that the tumor was positive for S-100 and negative for synaptophysin, chromogranin A, and pan keratin (AE1/AE3). The percentage of Ki-67 was 10 % in the hot spot area. Based on these clinicopathological findings, we initially considered the possibility of a myxoid liposarcoma, although we did not observe any lipoblasts. Therefore, we considered the possibility of an extraskeletal myxoid chondrosarcoma. As this tumor is very rare, we searched for the EWSR1-NR4A3 gene fusion using fluorescence in situ hybridization, which confirmed the diagnosis of extraskeletal myxoid chondrosarcoma. Positron emission tomography-computed tomography did not identify any obvious metastases, and we performed radical resection of our patient's vastus medialis and femur with a 3 cm margin. After the resection, we treated his resected femur using liquid nitrogen, and reconstructed his femur using autogenous fibula and plate fixation. No local recurrence or metastasis was observed at the 1-year follow-up.

Conclusion: Genetic testing is useful for diagnosing extraskeletal myxoid chondrosarcoma based on the presence of the EWSR1-NR4A3 gene fusion.

Keywords: EWSR1-NR4A3; Extraskeletal myxoid chondrosarcoma; Fluorescence in situ hybridization.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Radiography reveals a soft tissue mass with no calcification or periosteal reaction
Fig. 2
Fig. 2
Magnetic resonance imaging findings. a T1-weighted axial imaging reveals a soft tissue tumor with an isointense signal. b T2-weighted axial imaging reveals a soft tissue tumor with a high-intensity signal. c Axial imaging with gadolinium enhancement at the side edge of the partition structure
Fig. 3
Fig. 3
Computed tomography reveals a tumor without calcification or femur infiltration
Fig. 4
Fig. 4
Pathological and immunohistochemical findings. a Hematoxylin and eosin staining (×200). b Immunohistochemistry reveals positive expression of S-100. c Immunohistochemistry reveals that the percentage of Ki-67 was 10 % (×200)
Fig. 5
Fig. 5
Fluorescence in situ hybridization with two split signals (EWSR1 and NR4A3). Both of EWSR1 and NR4A3 split signals showed a pair of split (arrow) and fused (arrow head) patterns of red and green dyes. We counted 50 nuclei of tumor cells and they were assessed as positive if more than 10 % of tumor cells showed split signals. a With EWSR1, the split signal was detected in 44/50 (88 %) of the tumor cells. b With NR4A3, the split signal was detected in 47/50 (94 %) of the tumor cells
Fig. 6
Fig. 6
a Positron emission tomography-computed tomography reveals no obvious distant metastases. b An axial image with the maximum standardized uptake value of 3.1 (at the crosshairs)
Fig. 7
Fig. 7
a Gross appearance of the resected tumor. b Macroscopic findings of coronal section of resected tumor. Cystic cavities, hemorrhage and necrosis are found in the tumor. The tumor has a well-defined lobular architecture defined by fibrous septa
Fig. 8
Fig. 8
Postoperative radiography after the femur reconstruction

References

    1. Ibrahim ZA, Chan WH, Wong SL, Ong EJ, Narihan MZ. Extraskeletal myxoid chondrosarcoma of the thigh in a child: a case report. J Orthop Surg (Hong Kong) 2014;22(3):423–6. doi: 10.1177/230949901402200331. - DOI - PubMed
    1. Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000;13(8):900–8. doi: 10.1038/modpathol.3880161. - DOI - PubMed
    1. Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int. 2005;55(8):453–63. doi: 10.1111/j.1440-1827.2005.01853.x. - DOI - PubMed
    1. Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, et al. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet. 1995;4(12):2219–26. doi: 10.1093/hmg/4.12.2219. - DOI - PubMed
    1. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, et al. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene. 1996;12:229–35. - PubMed

Publication types

MeSH terms

Supplementary concepts